Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


rescriptor change
Jan 2, 2001

My last prescription has a change on it for Rescriptor. The usual dosage is 4 pills 3 times daily. The bottles now say 3 pills, two times daily. Is this a new regimen that others have been using? Thanks, mark

Response from Dr. Stryker

Dear Mark:

Best to ask your doc directly what he or she has in mind, but my guess is that rescriptor (AKA delavirdine) is being used as a "booster" to raise the blood level of another drug in your cocktail. Some protease inhibitors can be boosted in this manner, providing higher levels to inhibit HIV more continuously. The effect is similar to that seen with norvir/ritonavir, but better tolerated in some folks. This is a strategy that some are employing as we grow more comfortable with using combination therapy. RAS

Rick Stryker, M.D., M.P.H.



Previous
More and more meds-bcb
Next
RE: a failing cocktail?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement